Related Experiment Video
Updated: Oct 1, 2026

Structure-Guided Design and Development of Novel Cyclophilin A Inhibitors and Ganoderiol-F Derivatives: An In-Silico Approach
Published on: June 23, 2026
The role of cyclooxygenase inhibitors in cancer prevention
William F Anderson1, Asad Umar, Jaye L Viner
1Gastrointestinal & Other Cancers Research Group, National Cancer Institute, Division of Cancer Prevention, EPN, Room 2141, 6130 Executive Boulevard, Bethesda, MD 20892-7317, USA.
Abstract:
Carcinogenesis results from the long-term accumulation of genetic and epigenetic aberrations at the molecular level, which are under constant selection pressure for growth advantage. Recognizing that cancer is the result of this long-term, multi-step process provides opportunities for molecularly targeted cancer prevention. Ideally, chemopreventive agents should be low in toxicity, morbidity, and cost. Several individual agents and agent combinations are currently under evaluation in the U.S. National Cancer Institute s (NCI) chemoprevention agent development program. Nonsteroidal anti-inflammatory drugs (NSAIDs) that inhibit cyclooxygenase (COX) -1 and -2 are among the most promising classes of agents for targeted molecular prevention.
Insights
Molecularly targeted cancer prevention strategies are being developed. Nonsteroidal anti-inflammatory drugs (NSAIDs) targeting cyclooxygenase (COX) enzymes show promise for low-toxicity cancer prevention.
Area of Science:
- Oncology
- Molecular Biology
- Pharmacology
Background:
- Carcinogenesis is a multi-step process involving genetic and epigenetic changes under selection pressure.
- Understanding cancer development opens avenues for molecularly targeted prevention.
- Ideal chemopreventive agents require low toxicity, morbidity, and cost.
Purpose of the Study:
- To explore molecularly targeted cancer prevention strategies.
- To identify promising classes of chemopreventive agents.
Main Methods:
- Evaluation of individual agents and combinations in the U.S. National Cancer Institute's program.
- Focus on agents targeting molecular pathways involved in carcinogenesis.
Main Results:
- Nonsteroidal anti-inflammatory drugs (NSAIDs) inhibiting cyclooxygenase (COX)-1 and -2 are identified as highly promising.
- These agents represent a key class for targeted molecular prevention.
Conclusions:
- Targeted molecular prevention is a viable strategy for cancer control.
- NSAIDs offer a promising therapeutic avenue for cancer chemoprevention due to their COX inhibitory action.
Related Concept Videos
Inhibition of Cdk Activity
Inhibition of CDK Activity
Cancer Prevention
Some...
Cancer Prevention
Some...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
